• Skip to main content
  • Skip to primary sidebar
kleo_logo_final_3
  • About
    • Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Our Pipeline
  • Our Technologies
    • ARMs
    • SyAMs
    • MATEs
  • Careers
  • News & Events
  • Partnerships
  • Contact

News

Kleo Pharmaceuticals Appoints Thomas J. Lynch, Jr., MD, as Chairman of the Board

November 4, 2019 By maria

NEW HAVEN, Conn., Nov. 4, 2019 /PRNewswire/ -- Kleo Pharmaceuticals, Inc., a unique immuno-oncology company developing next-generation synthetic bispecific compounds designed to emulate or enhance the … [Read more...] about Kleo Pharmaceuticals Appoints Thomas J. Lynch, Jr., MD, as Chairman of the Board

Filed Under: News

New Haven biotech honored for work developing cancer-fighting drugs

October 22, 2019 By maria

Finding a cure for cancer is personal for many working at Kleo Pharmaceuticals in New Haven. Doug Manion, MD, the company’s CEO, has lost friends and family to the disease, as has the company’s … [Read more...] about New Haven biotech honored for work developing cancer-fighting drugs

Filed Under: News

Biotech Spinoff Attracts Kudos, $$, In Quest For Cancer Drug

October 22, 2019 By maria

It looks like a blue-tinted coffee maker with a toaster tucked underneath. It sounds like an old-fashioned fax machine. In fact, it’s a FACS. Make that “Flourescent Activated Cell Sorting” … [Read more...] about Biotech Spinoff Attracts Kudos, $$, In Quest For Cancer Drug

Filed Under: News

Murphy Endorses Biotech, BBQ, & Elicker

October 22, 2019 By maria

U.S. Sen. Chris Murphy swung by Science Park to endorse a new generation of economic development — and political leadership — in a city booming with biotech business talent. Murphy spent the … [Read more...] about Murphy Endorses Biotech, BBQ, & Elicker

Filed Under: News

Kleo Pharmaceuticals Announces Open-House Event To Celebrate Innovator of the Month Award

August 8, 2019 By morgan

New Haven, Conn., August 08, 2019 – Kleo Pharmaceuticals, Inc. (Kleo), an immuno-oncology company developing next-generation synthetic bispecific compounds designed to emulate or enhance the activity … [Read more...] about Kleo Pharmaceuticals Announces Open-House Event To Celebrate Innovator of the Month Award

Filed Under: News

Kleo Pharmaceuticals Announces a CD38 Targeting Antibody Recruiting Molecule (ARM™) to Treat Multiple Myeloma as the First Clinical Candidate in its Partnership with PeptiDream

June 18, 2019 By morgan

NEW HAVEN, Conn., June 18, 2019 /PRNewswire/ -- Kleo Pharmaceuticals, Inc. (Kleo), an immuno-oncology company developing next-generation synthetic bispecific compounds designed to emulate or enhance … [Read more...] about Kleo Pharmaceuticals Announces a CD38 Targeting Antibody Recruiting Molecule (ARM™) to Treat Multiple Myeloma as the First Clinical Candidate in its Partnership with PeptiDream

Filed Under: News

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

Recent Posts

Kleo Pharmaceuticals to Present at Piper Jaffray 31st Annual Healthcare Conference

Kleo Pharmaceuticals to Present at 2019 BIO Investor Forum

Thomas Lynch chairs former colleague’s cancer startup

Archive by Year

  • 2019 (20)
  • 2018 (4)
  • 2017 (1)

About

  • Company
  • Management
  • Board of Directors
  • Scientific Advisory Board

Our Pipeline

Our Technologies

  • ARMs
  • SyAMs
  • MATEs

Careers

News & Events

  • News Releases
  • Events

Partnerships

© 2019 Kleo Pharmaceuticals. All Rights Reserved.